Journal for ImmunoTherapy of Cancer (Nov 2023)

1212 Bioengineered tumour-targeted interleukin-12 selectively cures murine triple-negative breast cancer (TNBC)

  • Anguraj Sadanandam,
  • Chanthirika Ragulan,
  • Melanie Herpels,
  • Aslan Mansurov,
  • Jun Ishihara

DOI
https://doi.org/10.1136/jitc-2023-SITC2023.1212
Journal volume & issue
Vol. 11, no. Suppl 1

Abstract

Read online

No abstracts available.